跳至主要内容
临床试验/NCT03322943
NCT03322943已完成不适用

The Comparison About the Response of Ursodeoxycholic Acid in Primary Biliary Cholangitis Only and Primary Biliary Cholangitis With High Immune Globulin G or Aminotransferase at West China Hospital

West China Hospital1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2016年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
300
试验地点
1
主要终点
Description of demographics, clinical index after treatment

研究概览

简要总结

This study evaluates the different response of Ursodeoxycholic Acid in primary biliary cholangitis only and primary biliary cholangitis with high immune globulin G or aminotransferase at West China Hospital from 2008-2017.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
25 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with primary biliary cholangitis Treated with Ursodeoxycholic Acid in West China Hospital for at least 1 year

排除标准

  • Autoimmune hepatitis Primary sclerosing cholangitis

结局指标

主要结局

Description of demographics, clinical index after treatment

时间窗: up to 1 year

age,sex,ALT(IU/L),AST(IU/L),ALP(IU/L),GGT(IU/L),IgG(g/L)

次要结局

  • Evaluation whether the PBC patients have response after treatment(within 1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Li Yang

Principal Investigator

West China Hospital

研究点 (1)

Loading locations...

相似试验